Organization (Academic)
University of the Pacific
ClinicalTrials.gov lists University of the Pacific as lead sponsor of 16 trials. It has 4 active development programs and 4 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo University of the Pacific., via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers University of the Pacific: 16 lead-sponsored trials and 4 legal-entity registrations.
Disease areas (16)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Diabetes Mellitus | 3 |
| Pain | 3 |
| Abscess | 1 |
| Ankle Injuries | 1 |
| Arthralgia | 1 |
Showing 5 of 16 disease areas.
Trials by start year as sponsor or collaborator (11)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2024 | 2 |
| 2023 | 2 |
| 2021 | 1 |
| 2019 | 3 |
| 2017 | 1 |
| 2015 | 1 |
| 2014 | 1 |
| 2012 | 2 |
| 2009 | 2 |
Showing 10 of 11 years.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (4)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Diclofenac 1% Topical | Pain | Phase 3 | 1 |
| Diclofenac 1% Topical | Arthralgia | Phase 3 | 1 |
| "Hydrocortisone" | Pain | Phase 3 | 1 |
| "Hydrocortisone" | Arthralgia | Phase 3 | 1 |
Approved assets (4)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| EndoSequence | 1 |
| ProRoot MTA | 1 |
| Biodentine | 1 |
| "Hydrocortisone" | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 2 of 3 hit target (n=3) | 3 of 3 on time (n=3) |
Journals published in (24)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics | 5 |
| Journal of diabetes science and technology | 3 |
| Anatolian journal of cardiology | 2 |
| Diabetes care | 2 |
| Diabetes technology & therapeutics | 2 |
Showing 5 of 24 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 4 | 0 | 2013-12-17 |
Latest dated events (21)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2025-11-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-09-16 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-05-10 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2023-06-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2023-05 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 21 events.
Biomarkers this organization publishes on (193)
Shown in this order: most publications first.
Showing 5 of 193 biomarkers.
On Scientist.com
University of the Pacific is listed as a research supplier in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarker capability evidence.
Work with University of the Pacific on Scientist.com
For prices, more details, or to contact University of the Pacific, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.